Global Endoscopic Spinal Surgery Devices Market Anticipated to Reach US$ 1,084.9 Million by 2031

According to a recent market study published by Growth Market Reports, titled, “Global Endoscopic Spinal Surgery Devices Market is segmented into by Product Type, by Procedure Type, by Technology and by End-user and by Region: Size, Share, Trends and Opportunity Analysis, 2016-2031”, the market was valued at US$ 638.4 Million in 2022 and is expected to grow at a growth rate of 6.3 % by the year 2031.

Endoscopic spinal surgery devices are medical instruments and equipment used in minimally invasive procedures to treat spinal conditions. These devices are designed to access and visualize the spine through small incisions, reducing the need for large surgical openings and minimizing tissue damage.

Get Sample Report @ https://growthmarketreports.com/request-sample/5889

Specialized devices are utilized in endoscopic spinal surgery to perform the procedure with smaller incisions, which result in reduced trauma, less blood loss, and fast recovery.

On the basis of product type, the global endoscopic spinal surgery devices market is segregated into Endoscopes & Endoscopic Devices. The endoscopes segment is projected to expand at a considerable pace during the forecast period, as it helps in accurate identification and assessment of conditions. Spinal surgery using endoscope provides 90% or higher success rates.

Based on procedure type, the global endoscopic spinal surgery devices market is classified into transforaminal endoscopic procedures, interlaminar endoscopic procedures, endoscopic posterior foraminotomy & cervical discectomy, endoscopic visualized rhizotomy, and others. The transforaminal endoscopic procedures segment is projected to expand at a significant pace during the forecast period, as it offers less post-operative pain and scarring. The interlaminar endoscopic procedure segment is expected to grow at a rapid pace in the coming years, as it is widely accepted and utilized in the lumbar spine surgeries.

In terms of technology, the global endoscopic spinal surgery devices market is segregated into 2D endoscopic spinal surgery devices and 3D endoscopic spinal surgery devices. The 3D endoscopic spinal surgery devices segment is expected to grow at a rapid pace in the coming years, as it creates an immersive experience by offering a stereoscopic 3D view. It provides improved surgical accuracy and enhanced depth perception.

On the bases of end-user, the global endoscopic spinal surgery devices market is segregated into hospitals, specialty spinal clinics, and ambulatory surgical centers. The hospitals segment is expected to hold a significant market share during the forecast period, due to surgical expertise and availability of specialized spine surgeons in hospitals. The specialty spinal clinics segment is anticipated to grow at a rapid pace during the forecast period, as they perform advanced endoscopic procedures providing comprehensive spine care.

The COVID-19 pandemic has had a significant impact on various markets, including the endoscopic spinal surgery devices market. Healthcare systems around the world faced several challenges, such as supply chain disruption as the virus spread rapidly.

The pandemic restricted the global endoscopic spinal surgery devices market. The supply chain was disrupted in the initial stage of the lockdown, which declined the demand for endoscopes and endoscopic devices during the COVID-19 pandemic.

As per growth market reports by industry analyst Divyanka Sankhe, “Endoscopic spinal surgery devices are medical devices used in minimally invasive procedures to treat spinal disorders. Rising number of hospitals and spinal surgical clinics and increasing demand for Point-of-Care (POC) Solutions is propelling the demand for endoscopic spinal surgery devices during the forecast period.

Supply chain management is an essential part of any business. A supply chain contains a series of steps to get products from their original state to the customers. Raw materials used for manufacturing Endoscopic Spinal Surgery Devices are shipped to manufacturers to be processed into final products. Quality checks are performed throughout the production process by manufacturers to ensure the quality of the product.

Key Takeaways from the Study:

The players in the global endoscopic spinal surgery devices market include KARL STORZ SE & Co. KG, Stryker, joimax GmbH, MedicalTek Co., Ltd., RIWOspine GmbH, RZ Medizintechnik, Techcord, elliquence, MAXMORESPINE (Hoogland Spine Products GmbH), asap endoscopic Products GmbH, SPINENDOS GmbH, Advin Health Care, and others.

Recent Developments:

• In September 2023, EndoTheia Inc completed a first-in-human clinical study for technology that improves minimally invasive endoscopic surgery. The trial at Vanderbilt University achieved all primary and secondary endpoints without any adverse events. FDA recently named EndoTheia’s ENT endoscopic surgery technology a Breakthrough Device.

• In August 2023, Viseon started the U.S. commercial rollout and initial clinical use of its MaxView 4K advanced visualization system. The state-of-the-art system involves no capital equipment expense and occupies no operating room footprint. It features a single-use, sterile 4K imaging camera and a reusable, non-sterile 4K image control box.

• In October 2022, Johnson & Johnson MedTech announced that DePuy Synthes, The Orthopaedics Company of Johnson & Johnson, secured 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its TELIGEN System, an integrated technology platform that enables minimally invasive surgical transforaminal lumbar interbody fusion (MIS-TLIF) procedures through digital tools for visualization and access.

• In August 2022, Spineology launched OptiLIF Endo, an ultra-minimally invasive system that requires just one tubular retractor to integrate endoscopes and endoscopic equipment into lumbar interbody fusion procedures. OptiLIF Endo provides the power of direct endoscopic visualisation throughout the entirety of the procedure, including disc space access, decompression, discectomy/endplate preparation and interbody placement.

Target Audience:

• Supply-side: Manufacturer and distributors.

• Demand Side: Hospitals, Ambulatory Surgical Centres, Academic & Research Centres

• Regulatory Side: Approved regulatory bodies.

• Associations and Industry Bodies: World Health Organization (WHO), Food Drug Administration (FDA), Centers for Disease Control and Prevention (CDC), National Health Expenditure (NIH) etc.